Abstract
The efficacy and tolerability of aceclofenac (100 mg bid; n=109), a new non-steroidal anti-inflammatory agent, was compared to that of indomethacin (50 mg bid; n=110) in a multi-centre, 12-week, randomized, double-blind clinical trial in patients with rheumatoid arthritis. The efficacy of aceclofenac, on the basis of several clinical features characteristic for rheumatoid arthritis, was comparable to that of indomethacin. Patients in both treatment groups showed a notable and significant improvement during the study. Under aceclofenac treatment, the number of painful and swollen joints decreased by a median of six and nine, respectively, morning stiffness was shortened by 1 h, and the grip strength of both hands increased by a median of 8 mmHg. Pain at rest was relieved in 65.3% of aceclofenac-treated patients and in 67.1% of those treated with indomethacin (n.s.). With regard to safety, aceclofenac tended to be better tolerated than indomethacin. Among the 109 aceclofenac-treated patients, 26 incidents of adverse effects due to the drug were noted in 20 patients (18.4%). Sixty-four incidents of adverse events were documented in 32 (29.1%) of the 110 patients treated with indomethacin. The most common adverse events reported during treatment with aceclofenac were heartburn (four patients) and vertigo (three patients).
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Zvaifler NL (1973) The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 16:256–356
Grau M, Guasch J, Montero JL, Felipe A, Carrasco E, Juliá S (1991) Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac. Arzneimittelforschung/Drug Res 41:1265–1276
Cecchettin M, Cerea P, Torri G (1988) Therapeutic efficacy of aceclofenac and diclofenac in acute knee arthroses. Study of the E2-prostaglandin levels in the synovial fluid and in the serum. Clin Trials J 25:144–151
Díaz C, Rodríguez A, Geli C, Llobet JM, Tapounet R (1988) Comparison of aceclofenac and diclofenac in osteoarthritic pain. Curr Ther Res 44:252–256
Torrejón VA (1988) Treatment of severe rheumatic pain with aceclofenac: results of a comparative study vs placebo. Acta Ther 14:275–280
Sainz Olalla F (1989) Ahalgesic efficacy of aceclofenac. Double-blind study vs placebo in the treatment of odontalgia. Curr Ther Res 43:900–902
Bubani G (1988) The analgesic activity and tolerability of aceclofenac in the treatment of odontalgia. Clin Trials J 23: 244–253
Movilia PG (1988) Evaluation of analgesic activity and tolerability of aceclofenac in the treatment of postepisiotomy pain. Drugs Exp Clin Res 15:47–51
Ballesteros R, Ansoleaga JJ, Tapounet R (1990) The efficacy and tolerance of aceclofenac in rheumatoid arthritis. A double-blind study vs placebo. Clin Trials J 27:12–19
Giorgianni G, Ottaviani C, Soliano A, Campi N (1992) Efficacy and tolerability of aceclofenac versus ketoprofen in the treatment of rheumatoid arthritis. Curr Ther Res 51:175–183
Wassif W, Bjarnason I (1992) A comparison of the effects of aceclofenac and diclofenac on gastrointestinal blood loss. Br J Clin Res 3:109–114
Grupo de Estudio de Artritis Reumatoide (1992) Estudio de eficacia y tolerancia de aceclofenaco frente a ketoprofeno en el tratamiento de la artritis reumatoide. Rev Esp Reumatol 19: 263–268
Fehr K, Miehle W, Schattenkirchner M, Tillmann K (1989) Rheumatologie in Praxis und Klinik. Thieme, Stuttgart
Martín-Mola E, Gijón-Baños J (1995) Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis. Rheumatol Int 15:111–116
Furst DE, Dromgoole SH (1987) Indomethacin and sulindac. In: Paulus HE, Furst DE, Dromgoole SH (eds) Drugs for rheumatic disease. Churchill Livingstone. New York, pp 285–314
Anonymous (1994) Current problems in pharmacovigilance, vol 20. U. K. Committee on Safety of Medicines
Gøtzsche PC (1989) Patients' preference in indomethacin trials: an overview. Lancet 1:88–91
Accardo S, Seriolo B, Tirri G, Colombo B, Fumagali M, Lotti G, Pagliara L, Parnham MJ, Alepuz M (1995) Long term safety profile of aceclofenac in the treatment of articular pain. Eur J Rheumatol Inflam 15:35–41
Lichtenstein DR, Syngal S, Wolfe MM (1995) Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. The double-edged sword. Arthritis Rheum 38:5–18
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kornasoff, D., Maisenbacher, J., Bowdler, J. et al. The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis. Rheumatol Int 15, 225–230 (1996). https://doi.org/10.1007/BF00290375
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00290375